Shri Ahimsa Naturals IPO IPO

Shri Ahimsa Naturals Ltd

₹1,35,600 /1200 sharesMinimum Investment

Shri Ahimsa Naturals IPO IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
--₹119.00₹140.00₹21.00 (17.65%)

Shri Ahimsa Naturals IPO IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
25 Mar ‘25 - 27 Mar ‘25₹1,35,6001,200₹113 - ₹119
Issue SizeIPO Doc
73.81Cr
RHP PDF

Subscription rate

As of 27 Mar'25, 05:00 PM
Qualified Institutional Buyers21.23x
Non-Institutional Investor183.12x
Retail Individual Investor33.29x
Total57.57x

About Shri Ahimsa Naturals IPO

Shri Ahimsa Naturals Limited is engaged in extracting, manufacturing, and trading herbal extracts and caffeine-based products. The company primarily produces caffeine anhydrous natural, green coffee bean extracts (GCE), and crude caffeine. It processes crude caffeine from decaffeination plants in Vietnam and Mexico, extracting and refining it into its core products. Since 2022, it has also been manufacturing crude caffeine from tea and coffee waste. The company caters to industries such as food and beverage, nutraceuticals, cosmetics, and pharmaceuticals. It also trades in herbal extracts, including senna leaf P.E., ashwagandha extract, turmeric extract, and garcinia cambogia P.E. Shri Ahimsa Naturals operates from its registered office and manufacturing unit in Jaipur, Rajasthan and primarily exports its products to over 14 countries, including the USA, Germany, and the UK.;
Founded in
1990
Managing director
Mr. Nemi Chand Jain
Parent organisation
Shri Ahimsa Naturals Ltd

Strengths & Financials of Shri Ahimsa Naturals IPO

Strengths
Risks
The company operates a technologically advanced manufacturing facility in Jaipur, Rajasthan, with an installed capacity of 270 MTPA of caffeine anhydrous natural and 200 MTPA of green coffee bean extracts.
The company is ISO 9001:2015 certified for quality management systems, ISO 22000:2018 certified for food safety management systems, and ISO 45001:2018 certified for occupational health and safety management. Furthermore, the facility complies with hazard analysis and critical control points (HACCP) for food safety and good manufacturing practices (GMP) for quality assurance in production.
Ahimsa Naturals claims to have a dedicated in-house R&D and quality lab focused on process improvements and product innovation. The company states that its continuous research efforts help enhance product efficacy, maintain consistency, and improve manufacturing efficiency.
The company claims to have maintained long-standing relationships with customers and suppliers.
The company plans to invest Rs 30 crore in its wholly-owned subsidiary, Shri Ahimsa Healthcare Private Limited. Since this subsidiary is newly formed, its operational success remains uncertain and any negative developments could impact the company's overall financial performance.
The top 10 customers of the company contributed Rs 30.24 crore (74.28%), Rs 73.13 crore (93.66%), Rs 92.70 crore (89.02%), and Rs 50.46 crore (86.93%) to the order book in the period ended September 30, 2024, FY24, FY23, and FY22, respectively. Any failure to retain these key customers, expand the customer base, or a loss of business from these clients can adversely affect the company’s business and financial standing.
The top 10 suppliers of the company contributed Rs 16.13 crore (94.06%), Rs 46.97 crore (98.46%), Rs 37.56 crore (99.07%), and Rs 25.45 crore (99.27%) to purchases in the period ended September 30, 2024, FY24, FY23, and FY22, respectively. Any failure to retain these key suppliers can adversely affect the company’s business and financial standing.
The company has experienced instances of delayed filings related to GST. Any penalties, regulatory actions, or increased scrutiny could adversely impact the company’s business and financial condition.
As of February 28, 2025, the company had outstanding financial indebtedness of Rs 13.58 crore. Any failure to service or repay these loans could harm the company’s operations and financial position.
The company generated negative cash flows from investing activities amounting to Rs 2.70 crore, Rs 17.04 crore, Rs 9.77 crore, and Rs 5.83 crore for the period ended September 30, 2024, FY24, FY23, and FY22, respectively. Also, the company generated negative cash flows from financing activities of Rs 3.33 crore, Rs 3.50 crore, and Rs 5.99 crore for the period ended September 30, 2024, FY23, and FY22, respectively. Any inability to effectively manage cash outflows from financing activities in the future may adversely impact the company’s business, financial condition, and results of operations.

Shri Ahimsa Naturals IPO Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of Shri Ahimsa Naturals IPO IPO

Apply asPrice bandApply upto
Regular113 - 119₹2 - 5 Lakh
High Networth Individual113 - 119₹2 - 5 Lakh
For Shri Ahimsa Naturals IPO IPO, eligible investors can apply as Regular.